Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Biomarkers | Research

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

Authors: Zhimin Ye, Fangzheng Wang, Fengqin Yan, Lei Wang, Bin Li, Tongxin Liu, Fujun Hu, Mingxiang Jiang, Weiyang Li, Zhenfu Fu

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Background

The incidence of nasopharyngeal carcinoma (NPC) is rare, but a certain amount of mortality remains in NPC patients. Our study aimed to identify candidate genes as biomarkers for NPC screening, diagnosis, and therapy.

Methods

We investigated two microarray profile datasets GSE64634 and GSE12452 to screen the potential differentially expressed genes (DEGs) in NPC. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the DEGs were also performed. A protein-protein interaction (PPI) network of DEGs was constructed by STRING and visualized by Cytoscape software. The associated transcriptional factor regulatory network of the DEGs was also constructed.

Results

A total of 152 DEGs were identified from the GSE64634 and GSE12452 datasets, including 10 upregulated and 142 downregulated genes. Gene functional enrichment analysis indicated that these DEGs were enriched in the cilium movement, antimicrobial humoral response, O-glycan processing, mucosal immune response, carbohydrate transmembrane transporter activity, hormone biosynthetic process, neurotransmitter biosynthetic process, and drug metabolism-cytochrome P450 pathway. Five hub genes (DNALI1, RSPH4A, RSPH9, DNAI2, and ALDH3A1) and one significant module (score = 5.6) were obtained from the PPI network. Key transcriptional factors, such as SPI1, SIN3B, and GATA2, were identified with close interactions with these five hub DEGs from the gene-transcriptional factor network.

Conclusions

With the integrated bioinformatic analysis, numerous DEGs related to NPC were screened, and the hub DEGs we identified may be potential biomarkers for NPC.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):69–90.CrossRef Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):69–90.CrossRef
3.
go back to reference Zheng H, Dai W, Cheung AK, et al. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. Proc Natl Acad Sci USA. 2016;113:11283–8.CrossRef Zheng H, Dai W, Cheung AK, et al. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. Proc Natl Acad Sci USA. 2016;113:11283–8.CrossRef
4.
go back to reference Henderson BE, Louie E, Soohoo JJ, et al. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med. 1976;295:1101–6.CrossRef Henderson BE, Louie E, Soohoo JJ, et al. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med. 1976;295:1101–6.CrossRef
5.
go back to reference Bensouda Y, Kaikani W, Ahbeddou N, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(2):79–85.CrossRef Bensouda Y, Kaikani W, Ahbeddou N, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(2):79–85.CrossRef
6.
go back to reference Ngan HL, Wang L, Lo KW, et al. Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs. HPV-associated head and neck cancer. Cancers. 2018;10(7):210–30.CrossRef Ngan HL, Wang L, Lo KW, et al. Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs. HPV-associated head and neck cancer. Cancers. 2018;10(7):210–30.CrossRef
7.
go back to reference Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018. Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018.
8.
go back to reference Wang S, Cheng Q. Microarray analysis in drug discovery and clinical applications. Methods Mol Biol. 2006;316:49–65.PubMed Wang S, Cheng Q. Microarray analysis in drug discovery and clinical applications. Methods Mol Biol. 2006;316:49–65.PubMed
9.
go back to reference Olsen LR, Campos B, Barnkob MS, et al. Bioinformatics for cancer immunotherapy target discovery. Cancer Immunol Immunother. 2014;63:1235–49.CrossRef Olsen LR, Campos B, Barnkob MS, et al. Bioinformatics for cancer immunotherapy target discovery. Cancer Immunol Immunother. 2014;63:1235–49.CrossRef
10.
go back to reference Lou W, Chen J, Ding B, et al. Identication of invasion-metastasis-associated micro RNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. J Transl Med. 2018;16:266.CrossRef Lou W, Chen J, Ding B, et al. Identication of invasion-metastasis-associated micro RNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. J Transl Med. 2018;16:266.CrossRef
11.
go back to reference Quackenbush J. Microarray analysis and tumor classification. N Engl J Med. 2006;355:960.CrossRef Quackenbush J. Microarray analysis and tumor classification. N Engl J Med. 2006;355:960.CrossRef
12.
go back to reference Shen DW, Pouliot LM, Hall MD, et al. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64:706–21.CrossRef Shen DW, Pouliot LM, Hall MD, et al. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64:706–21.CrossRef
13.
go back to reference Schaue D, Mcbride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015;12:527–40.CrossRef Schaue D, Mcbride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015;12:527–40.CrossRef
14.
go back to reference Cully M. Targeted therapy: tipping the splicing balance to kill cancer cells. Nat Rev Cancer. 2018;18:209.CrossRef Cully M. Targeted therapy: tipping the splicing balance to kill cancer cells. Nat Rev Cancer. 2018;18:209.CrossRef
15.
go back to reference Sun Y, Hofbauer JP, Harada M, et al. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology. Cancer Lett. 2018;433:107–16.CrossRef Sun Y, Hofbauer JP, Harada M, et al. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology. Cancer Lett. 2018;433:107–16.CrossRef
16.
go back to reference Zhang YW, Zhong LK, Lou QW, et al. Study on the HPV-positive oropharyngeal cancer features gene based on GEO database by bioinformatic. Chin J Mod Appl Pharm. 2018;35(5):638–41. Zhang YW, Zhong LK, Lou QW, et al. Study on the HPV-positive oropharyngeal cancer features gene based on GEO database by bioinformatic. Chin J Mod Appl Pharm. 2018;35(5):638–41.
17.
go back to reference Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18:341.CrossRef Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18:341.CrossRef
18.
go back to reference Chen F, Shen C, Wang X, et al. Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis. Oncotarget. 2017;8(38):63738–49.PubMedPubMedCentral Chen F, Shen C, Wang X, et al. Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis. Oncotarget. 2017;8(38):63738–49.PubMedPubMedCentral
19.
go back to reference An F, Zhang Z, Xia M. Functional analysis of the nasopharyngeal carcinoma primary tumor associated gene interaction network. Molecular Medicine Reports. 2015;12(4):4975–80.CrossRef An F, Zhang Z, Xia M. Functional analysis of the nasopharyngeal carcinoma primary tumor associated gene interaction network. Molecular Medicine Reports. 2015;12(4):4975–80.CrossRef
20.
go back to reference Viswanadha R, Sale WS, Porter ME. Ciliary motility: regulation of axonemal dynein motors. Cold Spring Harb Perspect Biol. 2017;9. Viswanadha R, Sale WS, Porter ME. Ciliary motility: regulation of axonemal dynein motors. Cold Spring Harb Perspect Biol. 2017;9.
21.
go back to reference Shapiro A, Davis S, Manion M, et al. Primary ciliary dyskinesia (PCD). Am J Respir Crit Care Med. 2018;198:3–4.CrossRef Shapiro A, Davis S, Manion M, et al. Primary ciliary dyskinesia (PCD). Am J Respir Crit Care Med. 2018;198:3–4.CrossRef
22.
go back to reference Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017;49(1). Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017;49(1).
23.
go back to reference Parris TZ, Danielsson A, Nemes S, et al. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin Cancer Res. 2010;16:3860–74.CrossRef Parris TZ, Danielsson A, Nemes S, et al. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma. Clin Cancer Res. 2010;16:3860–74.CrossRef
24.
go back to reference Frommer A, Hjeij R, Loges NT, et al. Immunofluorescence analysis and diagnosis of primary ciliary dyskinesia with radial spoke defects. Am J Respir Cell Mol Biol. 2015;53:563–73.CrossRef Frommer A, Hjeij R, Loges NT, et al. Immunofluorescence analysis and diagnosis of primary ciliary dyskinesia with radial spoke defects. Am J Respir Cell Mol Biol. 2015;53:563–73.CrossRef
25.
go back to reference Chin YM, Ping TL, Abdul AN, et al. Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort. Int J Cancer. 2016;139:1731–9.CrossRef Chin YM, Ping TL, Abdul AN, et al. Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort. Int J Cancer. 2016;139:1731–9.CrossRef
26.
go back to reference Counihan JL, Wiggenhorn AL, Anderson KE, Nomura DK. Chemoproteomics-enabled covalent ligand screening reveals ALDH3A1 as a lung cancer therapy target. ACS Chem Biol. 2018;13:1970–7.CrossRef Counihan JL, Wiggenhorn AL, Anderson KE, Nomura DK. Chemoproteomics-enabled covalent ligand screening reveals ALDH3A1 as a lung cancer therapy target. ACS Chem Biol. 2018;13:1970–7.CrossRef
27.
go back to reference Patel M, Lu L, Zander DS, et al. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer. 2008;59:340–9.CrossRef Patel M, Lu L, Zander DS, et al. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer. 2008;59:340–9.CrossRef
28.
go back to reference Zhang YW, Fang L, Zheng XW, et al. Study advance on epigenetic regulation of cytochrome p450 enzymes. Chin J Mod Appl Pharm. 2017;34(2):293–7. Zhang YW, Fang L, Zheng XW, et al. Study advance on epigenetic regulation of cytochrome p450 enzymes. Chin J Mod Appl Pharm. 2017;34(2):293–7.
29.
go back to reference Mittal B, Tulsyan S, Kumar S, et al. Cytochrome p450 in cancer susceptibility and treatment. Advances in clinical chemistry. 2015;71:77–139.CrossRef Mittal B, Tulsyan S, Kumar S, et al. Cytochrome p450 in cancer susceptibility and treatment. Advances in clinical chemistry. 2015;71:77–139.CrossRef
30.
go back to reference Tiwawech D, Srivatanakul P, Karalak A, et al. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Letters. 2006;241(1):0–141.CrossRef Tiwawech D, Srivatanakul P, Karalak A, et al. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Letters. 2006;241(1):0–141.CrossRef
31.
go back to reference Hildesheim A, Anderson LM. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 1997;89(16):1207–12.CrossRef Hildesheim A, Anderson LM. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 1997;89(16):1207–12.CrossRef
32.
go back to reference Moreau-Gachelin F, Tavitian A, et al. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988;331:277–80.CrossRef Moreau-Gachelin F, Tavitian A, et al. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988;331:277–80.CrossRef
33.
go back to reference Lewis MJ, Liu J, Libby EF, et al. SIN3A and SIN3B differentially regulate breast cancer metastasis. Oncotarget. 2016;7:78713–25.PubMedPubMedCentral Lewis MJ, Liu J, Libby EF, et al. SIN3A and SIN3B differentially regulate breast cancer metastasis. Oncotarget. 2016;7:78713–25.PubMedPubMedCentral
34.
go back to reference Plymate SR, Bhatt RS, et al. Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2. Cancer Cell. 2015;27:158–9.CrossRef Plymate SR, Bhatt RS, et al. Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2. Cancer Cell. 2015;27:158–9.CrossRef
Metadata
Title
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
Authors
Zhimin Ye
Fangzheng Wang
Fengqin Yan
Lei Wang
Bin Li
Tongxin Liu
Fujun Hu
Mingxiang Jiang
Weiyang Li
Zhenfu Fu
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Biomarkers
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1605-9

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue